A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.
As a winner of the Press Ganey HX Guardian of Excellence Award®, Hedrick is in the top 5% of healthcare providers nationwide in delivering rehabilitation services in the last year.
New study led by Saint Luke’s Mid America Heart Institute cardiologists reveals lower risk of all-cause and cause-specific mortality associated with higher docosahexaenoic acid (DHA) blood levels